Moderna Total Assets 2017-2021 | MRNA

Moderna total assets from 2017 to 2021. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Moderna total assets for the quarter ending June 30, 2021 were $16.153B, a 363.37% increase year-over-year.
  • Moderna total assets for 2020 were $7.337B, a 361.6% increase from 2019.
  • Moderna total assets for 2019 were $1.589B, a 19% decline from 2018.
  • Moderna total assets for 2018 were $1.962B, a 80.93% increase from 2017.
Moderna Annual Total Assets
(Millions of US $)
2020 $7,337
2019 $1,589
2018 $1,962
2017 $1,084
2016 $1,417
Moderna Quarterly Total Assets
(Millions of US $)
2021-06-30 $16,153
2021-03-31 $12,694
2020-12-31 $7,337
2020-09-30 $4,651
2020-06-30 $3,486
2020-03-31 $2,068
2019-12-31 $1,589
2019-09-30 $1,591
2019-06-30 $1,685
2019-03-31 $1,806
2018-12-31 $1,962
2018-09-30 $0
2018-06-30 $0
2018-03-31 $0
2017-12-31 $1,084
2016-12-31 $1,417
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $165.027B $0.803B
Moderna Inc. is a clinical stage biotechnology company pioneering messenger RNA therapeutics and vaccines for patients. The company's product pipeline which is in clinical stage consists of mRNA-1647 for Cytomegalovirus Infectious Disease, mRNA-4157 for Solid tumors, mRNA-2416 for lymphoma and mRNA- 2752 for Relapsed/Refractory solid tumors malignancies. Moderna Inc. is based in Cambridge, United States.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $132.971B 8.85
Bio-Rad Laboratories (BIO.B) United States $22.624B 48.22
QIAGEN (QGEN) Netherlands $12.001B 20.32
Biohaven Pharmaceutical Holding (BHVN) United States $8.691B 0.00
Emergent Biosolutions (EBS) United States $2.870B 6.92
Arcus Biosciences (RCUS) United States $2.690B 0.00
Myovant Sciences (MYOV) United Kingdom $2.182B 0.00
ADC Therapeutics SA (ADCT) Switzerland $2.045B 0.00
Zymeworks (ZYME) Canada $1.373B 0.00
Ambrx Biopharma (AMAM) United States $0.501B 0.00
SQZ Biotechnologies (SQZ) United States $0.442B 0.00
Enzo Biochem (ENZ) United States $0.174B 51.29